The Centers for Disease Control and Prevention (CDC) Director Dr. Rochelle Walensky has tested positive for COVID-19.
The general public health agency announced Saturday via its website that Walensky tested positive for the virus on Friday night, adding that she’s up so far together with her vaccines and only experiencing mild symptoms.
Walensky is following the CDC’s guidelines for isolation and precautions for individuals with COVID-19, so she has been isolated at home after receiving her test result.
Per the rules, a one that has tested positive for SARS-CoV-2 should stay at home for no less than 5 days and isolate from other people inside their home. It is because a one that contracted the virus is probably going most infectious in the course of the first 5 days.
The patient can be advised to wear a high-quality mask if there are other people at home, but they need to separate from others as much as possible and even use a separate bathroom, if possible.
Sharing personal home goods, like cups, towels, and utensils is strongly discouraged. The patient should monitor their symptoms and seek emergency medical care should they experience severe symptoms, comparable to difficulty respiratory.
Despite the diagnosis, the CDC director intends to maintain going together with her work engagements by participating in her planned meetings virtually.
CDC senior staff and shut contacts of Walensky have been informed of her positive test result and are currently taking appropriate motion to observe their health.
Walensky’s diagnosis got here amid the falling COVID-19 cases in america because the country moves into the autumn season, reported CNN.
But experts warned that cases could begin to climb again in winter like up to now two pandemic winters. Because of this, they strongly encourage everyone to be up so far with their vaccines and get boosted for more protection against COVID-19.
The CDC advisable the updated bivalent COVID-19 boosters from Pfizer and Moderna in September since they aim the unique strain and the newer omicron subvariants.
Earlier this week, the general public health agency also signed a memo allowing adults aged 18 and above to get the Novavax monovalent booster in the event that they couldn’t receive the mRNA bivalent booster.